Sym023

· Symphogen A/S

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Sym023, covering 2021-10-12 to 2024-06-26. Get the full timeline:

Most recent: Clinical Trial Update: Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies [Phase 1]

See pricing